William Chou

Vorstandsvorsitzender bei PASSAGE BIO, INC.

Vermögen: - $ am 30.04.2024

51 Jahre

Consumer Services

Health Technology

Aktive Positionen von William Chou

Unternehmen	Position	Beginn	Ende
PASSAGE BIO, INC.	Direktor/Vorstandsmitglied	10.10.2022	-
	Vorstandsvorsitzender	10.10.2022	-
	Präsident	-	-

Unternehmen	Position	Beginn	Ende
Aruvant Sciences, Inc. Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY.	Vorstandsvorsitzender	19.11.2019	-

Yale School of Management	Masters Business Admin
University of Pittsburgh School of Medicine	Doctorate Degree
Princeton University	Undergraduate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Consumer Services	4
Health Technology	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
PASSAGE BIO, INC.	Health Technology

Private Unternehmen	1
Aruvant Sciences, Inc. Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY.	Health Technology

Private Unternehmen

Health Technology